nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—Lacrimation—Estramustine—prostate cancer	0.0239	0.0417	CcSEcCtD
Levocabastine—Lacrimation increased—Estramustine—prostate cancer	0.0153	0.0266	CcSEcCtD
Levocabastine—Lacrimation increased—Cabazitaxel—prostate cancer	0.0114	0.0199	CcSEcCtD
Levocabastine—Eye pain—Estramustine—prostate cancer	0.0113	0.0197	CcSEcCtD
Levocabastine—Ocular hyperaemia—Estradiol—prostate cancer	0.0106	0.0185	CcSEcCtD
Levocabastine—Eyelid oedema—Estradiol—prostate cancer	0.00984	0.0172	CcSEcCtD
Levocabastine—Visual disturbance—Nilutamide—prostate cancer	0.00956	0.0167	CcSEcCtD
Levocabastine—Visual disturbance—Estradiol valerate/Dienogest—prostate cancer	0.00898	0.0157	CcSEcCtD
Levocabastine—Visual impairment—Nilutamide—prostate cancer	0.00604	0.0105	CcSEcCtD
Levocabastine—Visual disturbance—Ethinyl Estradiol—prostate cancer	0.00583	0.0102	CcSEcCtD
Levocabastine—Visual impairment—Estradiol valerate/Dienogest—prostate cancer	0.00567	0.0099	CcSEcCtD
Levocabastine—Lacrimation—Docetaxel—prostate cancer	0.00544	0.00949	CcSEcCtD
Levocabastine—Erythema—Flutamide—prostate cancer	0.00543	0.00947	CcSEcCtD
Levocabastine—Cough—Abiraterone—prostate cancer	0.00521	0.00909	CcSEcCtD
Levocabastine—Erythema—Degarelix—prostate cancer	0.00487	0.0085	CcSEcCtD
Levocabastine—Cough—Nilutamide—prostate cancer	0.00476	0.0083	CcSEcCtD
Levocabastine—Visual disturbance—Conjugated Estrogens—prostate cancer	0.00475	0.00829	CcSEcCtD
Levocabastine—Erythema—Cabazitaxel—prostate cancer	0.00459	0.00801	CcSEcCtD
Levocabastine—Dry mouth—Nilutamide—prostate cancer	0.00454	0.00792	CcSEcCtD
Levocabastine—Pharyngitis—Bicalutamide—prostate cancer	0.00449	0.00783	CcSEcCtD
Levocabastine—Dyspnoea—Estramustine—prostate cancer	0.00447	0.0078	CcSEcCtD
Levocabastine—Visual impairment—Bicalutamide—prostate cancer	0.00436	0.0076	CcSEcCtD
Levocabastine—Dyspnoea—Abiraterone—prostate cancer	0.00434	0.00758	CcSEcCtD
Levocabastine—Fatigue—Abiraterone—prostate cancer	0.0042	0.00733	CcSEcCtD
Levocabastine—Pain—Estrone—prostate cancer	0.0041	0.00715	CcSEcCtD
Levocabastine—Dry mouth—Degarelix—prostate cancer	0.00406	0.00708	CcSEcCtD
Levocabastine—Cough—Cabazitaxel—prostate cancer	0.004	0.00699	CcSEcCtD
Levocabastine—Dyspnoea—Nilutamide—prostate cancer	0.00397	0.00692	CcSEcCtD
Levocabastine—Somnolence—Flutamide—prostate cancer	0.00394	0.00687	CcSEcCtD
Levocabastine—Dry mouth—Cabazitaxel—prostate cancer	0.00382	0.00667	CcSEcCtD
Levocabastine—Fatigue—Flutamide—prostate cancer	0.00382	0.00666	CcSEcCtD
Levocabastine—Pain—Nilutamide—prostate cancer	0.00381	0.00664	CcSEcCtD
Levocabastine—Visual disturbance—Estradiol—prostate cancer	0.0038	0.00664	CcSEcCtD
Levocabastine—Pharyngitis—Ethinyl Estradiol—prostate cancer	0.00379	0.00662	CcSEcCtD
Levocabastine—Visual impairment—Ethinyl Estradiol—prostate cancer	0.00368	0.00643	CcSEcCtD
Levocabastine—Lacrimation—Epirubicin—prostate cancer	0.00367	0.0064	CcSEcCtD
Levocabastine—Fatigue—Estradiol valerate/Dienogest—prostate cancer	0.00361	0.00629	CcSEcCtD
Levocabastine—Pain—Estradiol valerate/Dienogest—prostate cancer	0.00358	0.00624	CcSEcCtD
Levocabastine—Dyspnoea—Degarelix—prostate cancer	0.00354	0.00618	CcSEcCtD
Levocabastine—Asthenia—Abiraterone—prostate cancer	0.0035	0.0061	CcSEcCtD
Levocabastine—Lacrimation increased—Docetaxel—prostate cancer	0.00347	0.00606	CcSEcCtD
Levocabastine—Cough—Bicalutamide—prostate cancer	0.00344	0.00599	CcSEcCtD
Levocabastine—Fatigue—Degarelix—prostate cancer	0.00343	0.00598	CcSEcCtD
Levocabastine—Pain—Degarelix—prostate cancer	0.0034	0.00593	CcSEcCtD
Levocabastine—Lacrimation—Doxorubicin—prostate cancer	0.0034	0.00592	CcSEcCtD
Levocabastine—Lacrimation increased—Capecitabine—prostate cancer	0.00336	0.00586	CcSEcCtD
Levocabastine—Dyspnoea—Cabazitaxel—prostate cancer	0.00334	0.00583	CcSEcCtD
Levocabastine—Dry mouth—Bicalutamide—prostate cancer	0.00328	0.00572	CcSEcCtD
Levocabastine—Fatigue—Cabazitaxel—prostate cancer	0.00323	0.00563	CcSEcCtD
Levocabastine—Pain—Cabazitaxel—prostate cancer	0.0032	0.00559	CcSEcCtD
Levocabastine—Asthenia—Nilutamide—prostate cancer	0.00319	0.00557	CcSEcCtD
Levocabastine—Asthenia—Flutamide—prostate cancer	0.00318	0.00555	CcSEcCtD
Levocabastine—Rash—Estramustine—prostate cancer	0.00316	0.00552	CcSEcCtD
Levocabastine—Dermatitis—Estramustine—prostate cancer	0.00316	0.00551	CcSEcCtD
Levocabastine—Headache—Estramustine—prostate cancer	0.00314	0.00548	CcSEcCtD
Levocabastine—Pharyngitis—Goserelin—prostate cancer	0.00312	0.00545	CcSEcCtD
Levocabastine—Pharyngitis—Conjugated Estrogens—prostate cancer	0.00309	0.0054	CcSEcCtD
Levocabastine—Rash—Abiraterone—prostate cancer	0.00307	0.00536	CcSEcCtD
Levocabastine—Dermatitis—Abiraterone—prostate cancer	0.00307	0.00535	CcSEcCtD
Levocabastine—Rash—Estrone—prostate cancer	0.00302	0.00527	CcSEcCtD
Levocabastine—Dermatitis—Estrone—prostate cancer	0.00302	0.00527	CcSEcCtD
Levocabastine—Visual impairment—Conjugated Estrogens—prostate cancer	0.003	0.00524	CcSEcCtD
Levocabastine—Headache—Estrone—prostate cancer	0.003	0.00524	CcSEcCtD
Levocabastine—Asthenia—Estradiol valerate/Dienogest—prostate cancer	0.003	0.00523	CcSEcCtD
Levocabastine—Nausea—Estramustine—prostate cancer	0.00298	0.0052	CcSEcCtD
Levocabastine—Cough—Ethinyl Estradiol—prostate cancer	0.0029	0.00507	CcSEcCtD
Levocabastine—Dyspnoea—Bicalutamide—prostate cancer	0.00286	0.005	CcSEcCtD
Levocabastine—Somnolence—Bicalutamide—prostate cancer	0.00286	0.00498	CcSEcCtD
Levocabastine—Asthenia—Degarelix—prostate cancer	0.00285	0.00498	CcSEcCtD
Levocabastine—Nausea—Estrone—prostate cancer	0.00285	0.00497	CcSEcCtD
Levocabastine—Rash—Nilutamide—prostate cancer	0.00281	0.0049	CcSEcCtD
Levocabastine—Dermatitis—Nilutamide—prostate cancer	0.0028	0.00489	CcSEcCtD
Levocabastine—Rash—Flutamide—prostate cancer	0.00279	0.00487	CcSEcCtD
Levocabastine—Dermatitis—Flutamide—prostate cancer	0.00279	0.00487	CcSEcCtD
Levocabastine—Headache—Nilutamide—prostate cancer	0.00279	0.00486	CcSEcCtD
Levocabastine—Headache—Flutamide—prostate cancer	0.00278	0.00484	CcSEcCtD
Levocabastine—Fatigue—Bicalutamide—prostate cancer	0.00277	0.00483	CcSEcCtD
Levocabastine—Pain—Bicalutamide—prostate cancer	0.00275	0.00479	CcSEcCtD
Levocabastine—Erythema—Goserelin—prostate cancer	0.00274	0.00478	CcSEcCtD
Levocabastine—Erythema—Conjugated Estrogens—prostate cancer	0.00271	0.00473	CcSEcCtD
Levocabastine—Asthenia—Cabazitaxel—prostate cancer	0.00269	0.00469	CcSEcCtD
Levocabastine—Stinging—Epirubicin—prostate cancer	0.00266	0.00465	CcSEcCtD
Levocabastine—Nausea—Nilutamide—prostate cancer	0.00264	0.00461	CcSEcCtD
Levocabastine—Rash—Estradiol valerate/Dienogest—prostate cancer	0.00264	0.0046	CcSEcCtD
Levocabastine—Dermatitis—Estradiol valerate/Dienogest—prostate cancer	0.00263	0.0046	CcSEcCtD
Levocabastine—Nausea—Flutamide—prostate cancer	0.00263	0.00459	CcSEcCtD
Levocabastine—Headache—Estradiol valerate/Dienogest—prostate cancer	0.00262	0.00457	CcSEcCtD
Levocabastine—Rash—Degarelix—prostate cancer	0.00251	0.00437	CcSEcCtD
Levocabastine—Dermatitis—Degarelix—prostate cancer	0.0025	0.00437	CcSEcCtD
Levocabastine—Headache—Degarelix—prostate cancer	0.00249	0.00435	CcSEcCtD
Levocabastine—Eye pain—Capecitabine—prostate cancer	0.00249	0.00434	CcSEcCtD
Levocabastine—Nausea—Estradiol valerate/Dienogest—prostate cancer	0.00248	0.00433	CcSEcCtD
Levocabastine—Pharyngitis—Estradiol—prostate cancer	0.00248	0.00432	CcSEcCtD
Levocabastine—Stinging—Doxorubicin—prostate cancer	0.00246	0.0043	CcSEcCtD
Levocabastine—Visual disturbance—Docetaxel—prostate cancer	0.00245	0.00427	CcSEcCtD
Levocabastine—Visual impairment—Estradiol—prostate cancer	0.0024	0.00419	CcSEcCtD
Levocabastine—Cough—Goserelin—prostate cancer	0.00239	0.00417	CcSEcCtD
Levocabastine—Cough—Conjugated Estrogens—prostate cancer	0.00237	0.00413	CcSEcCtD
Levocabastine—Nausea—Degarelix—prostate cancer	0.00236	0.00412	CcSEcCtD
Levocabastine—Headache—Cabazitaxel—prostate cancer	0.00235	0.00409	CcSEcCtD
Levocabastine—Fatigue—Ethinyl Estradiol—prostate cancer	0.00234	0.00408	CcSEcCtD
Levocabastine—Lacrimation increased—Epirubicin—prostate cancer	0.00234	0.00408	CcSEcCtD
Levocabastine—Pharyngitis—Mitoxantrone—prostate cancer	0.00231	0.00402	CcSEcCtD
Levocabastine—Asthenia—Bicalutamide—prostate cancer	0.00231	0.00402	CcSEcCtD
Levocabastine—Dry mouth—Goserelin—prostate cancer	0.00228	0.00398	CcSEcCtD
Levocabastine—Nausea—Cabazitaxel—prostate cancer	0.00222	0.00388	CcSEcCtD
Levocabastine—Erythema—Estradiol—prostate cancer	0.00217	0.00379	CcSEcCtD
Levocabastine—Lacrimation increased—Doxorubicin—prostate cancer	0.00217	0.00378	CcSEcCtD
Levocabastine—Rash—Bicalutamide—prostate cancer	0.00203	0.00353	CcSEcCtD
Levocabastine—Dermatitis—Bicalutamide—prostate cancer	0.00202	0.00353	CcSEcCtD
Levocabastine—Erythema—Mitoxantrone—prostate cancer	0.00202	0.00353	CcSEcCtD
Levocabastine—Headache—Bicalutamide—prostate cancer	0.00201	0.00351	CcSEcCtD
Levocabastine—Dyspnoea—Goserelin—prostate cancer	0.00199	0.00348	CcSEcCtD
Levocabastine—Somnolence—Goserelin—prostate cancer	0.00199	0.00347	CcSEcCtD
Levocabastine—Dyspnoea—Conjugated Estrogens—prostate cancer	0.00197	0.00344	CcSEcCtD
Levocabastine—Somnolence—Conjugated Estrogens—prostate cancer	0.00197	0.00343	CcSEcCtD
Levocabastine—Asthenia—Ethinyl Estradiol—prostate cancer	0.00195	0.0034	CcSEcCtD
Levocabastine—Fatigue—Goserelin—prostate cancer	0.00193	0.00336	CcSEcCtD
Levocabastine—Pain—Goserelin—prostate cancer	0.00191	0.00333	CcSEcCtD
Levocabastine—Fatigue—Conjugated Estrogens—prostate cancer	0.00191	0.00333	CcSEcCtD
Levocabastine—Nausea—Bicalutamide—prostate cancer	0.00191	0.00333	CcSEcCtD
Levocabastine—Cough—Estradiol—prostate cancer	0.00189	0.00331	CcSEcCtD
Levocabastine—Pain—Conjugated Estrogens—prostate cancer	0.00189	0.0033	CcSEcCtD
Levocabastine—Dry mouth—Estradiol—prostate cancer	0.00181	0.00315	CcSEcCtD
Levocabastine—Cough—Mitoxantrone—prostate cancer	0.00177	0.00308	CcSEcCtD
Levocabastine—Eye pain—Epirubicin—prostate cancer	0.00173	0.00303	CcSEcCtD
Levocabastine—Rash—Ethinyl Estradiol—prostate cancer	0.00171	0.00299	CcSEcCtD
Levocabastine—Dermatitis—Ethinyl Estradiol—prostate cancer	0.00171	0.00298	CcSEcCtD
Levocabastine—Headache—Ethinyl Estradiol—prostate cancer	0.0017	0.00297	CcSEcCtD
Levocabastine—Nausea—Ethinyl Estradiol—prostate cancer	0.00161	0.00281	CcSEcCtD
Levocabastine—Eye pain—Doxorubicin—prostate cancer	0.00161	0.0028	CcSEcCtD
Levocabastine—Asthenia—Goserelin—prostate cancer	0.0016	0.0028	CcSEcCtD
Levocabastine—Pharyngitis—Docetaxel—prostate cancer	0.00159	0.00278	CcSEcCtD
Levocabastine—Asthenia—Conjugated Estrogens—prostate cancer	0.00159	0.00277	CcSEcCtD
Levocabastine—Dyspnoea—Estradiol—prostate cancer	0.00158	0.00276	CcSEcCtD
Levocabastine—Somnolence—Estradiol—prostate cancer	0.00158	0.00275	CcSEcCtD
Levocabastine—Visual impairment—Docetaxel—prostate cancer	0.00155	0.0027	CcSEcCtD
Levocabastine—Pharyngitis—Capecitabine—prostate cancer	0.00154	0.00269	CcSEcCtD
Levocabastine—Fatigue—Estradiol—prostate cancer	0.00153	0.00267	CcSEcCtD
Levocabastine—Pain—Estradiol—prostate cancer	0.00152	0.00264	CcSEcCtD
Levocabastine—Visual impairment—Capecitabine—prostate cancer	0.0015	0.00261	CcSEcCtD
Levocabastine—Dyspnoea—Mitoxantrone—prostate cancer	0.00147	0.00257	CcSEcCtD
Levocabastine—Cough—Etoposide—prostate cancer	0.00147	0.00256	CcSEcCtD
Levocabastine—Somnolence—Mitoxantrone—prostate cancer	0.00147	0.00256	CcSEcCtD
Levocabastine—Fatigue—Mitoxantrone—prostate cancer	0.00142	0.00248	CcSEcCtD
Levocabastine—Pain—Mitoxantrone—prostate cancer	0.00141	0.00246	CcSEcCtD
Levocabastine—Rash—Goserelin—prostate cancer	0.00141	0.00246	CcSEcCtD
Levocabastine—Dermatitis—Goserelin—prostate cancer	0.00141	0.00246	CcSEcCtD
Levocabastine—Headache—Goserelin—prostate cancer	0.0014	0.00244	CcSEcCtD
Levocabastine—Erythema—Docetaxel—prostate cancer	0.0014	0.00244	CcSEcCtD
Levocabastine—Rash—Conjugated Estrogens—prostate cancer	0.0014	0.00244	CcSEcCtD
Levocabastine—Dermatitis—Conjugated Estrogens—prostate cancer	0.00139	0.00243	CcSEcCtD
Levocabastine—Headache—Conjugated Estrogens—prostate cancer	0.00139	0.00242	CcSEcCtD
Levocabastine—Erythema—Capecitabine—prostate cancer	0.00135	0.00236	CcSEcCtD
Levocabastine—Nausea—Goserelin—prostate cancer	0.00133	0.00232	CcSEcCtD
Levocabastine—Nausea—Conjugated Estrogens—prostate cancer	0.00132	0.00229	CcSEcCtD
Levocabastine—Asthenia—Estradiol—prostate cancer	0.00127	0.00222	CcSEcCtD
Levocabastine—Dyspnoea—Etoposide—prostate cancer	0.00122	0.00214	CcSEcCtD
Levocabastine—Somnolence—Etoposide—prostate cancer	0.00122	0.00213	CcSEcCtD
Levocabastine—Cough—Docetaxel—prostate cancer	0.00122	0.00213	CcSEcCtD
Levocabastine—Erythema—Prednisone—prostate cancer	0.00121	0.0021	CcSEcCtD
Levocabastine—Asthenia—Mitoxantrone—prostate cancer	0.00118	0.00207	CcSEcCtD
Levocabastine—Fatigue—Etoposide—prostate cancer	0.00118	0.00207	CcSEcCtD
Levocabastine—Cough—Capecitabine—prostate cancer	0.00118	0.00206	CcSEcCtD
Levocabastine—Pain—Etoposide—prostate cancer	0.00117	0.00205	CcSEcCtD
Levocabastine—Dry mouth—Docetaxel—prostate cancer	0.00116	0.00203	CcSEcCtD
Levocabastine—Dry mouth—Capecitabine—prostate cancer	0.00113	0.00197	CcSEcCtD
Levocabastine—Rash—Estradiol—prostate cancer	0.00112	0.00195	CcSEcCtD
Levocabastine—Dermatitis—Estradiol—prostate cancer	0.00112	0.00195	CcSEcCtD
Levocabastine—Headache—Estradiol—prostate cancer	0.00111	0.00194	CcSEcCtD
Levocabastine—Pharyngitis—Epirubicin—prostate cancer	0.00108	0.00188	CcSEcCtD
Levocabastine—Nausea—Estradiol—prostate cancer	0.00105	0.00184	CcSEcCtD
Levocabastine—Visual impairment—Epirubicin—prostate cancer	0.00104	0.00182	CcSEcCtD
Levocabastine—Rash—Mitoxantrone—prostate cancer	0.00104	0.00182	CcSEcCtD
Levocabastine—Dermatitis—Mitoxantrone—prostate cancer	0.00104	0.00181	CcSEcCtD
Levocabastine—Headache—Mitoxantrone—prostate cancer	0.00103	0.0018	CcSEcCtD
Levocabastine—Dyspnoea—Docetaxel—prostate cancer	0.00102	0.00178	CcSEcCtD
Levocabastine—Somnolence—Docetaxel—prostate cancer	0.00101	0.00177	CcSEcCtD
Levocabastine—Pharyngitis—Doxorubicin—prostate cancer	0.000995	0.00174	CcSEcCtD
Levocabastine—Asthenia—Etoposide—prostate cancer	0.000985	0.00172	CcSEcCtD
Levocabastine—Dyspnoea—Capecitabine—prostate cancer	0.000985	0.00172	CcSEcCtD
Levocabastine—Fatigue—Docetaxel—prostate cancer	0.000984	0.00172	CcSEcCtD
Levocabastine—Nausea—Mitoxantrone—prostate cancer	0.000981	0.00171	CcSEcCtD
Levocabastine—Pain—Docetaxel—prostate cancer	0.000976	0.0017	CcSEcCtD
Levocabastine—Visual impairment—Doxorubicin—prostate cancer	0.000966	0.00169	CcSEcCtD
Levocabastine—Fatigue—Capecitabine—prostate cancer	0.000953	0.00166	CcSEcCtD
Levocabastine—Pain—Capecitabine—prostate cancer	0.000945	0.00165	CcSEcCtD
Levocabastine—Erythema—Epirubicin—prostate cancer	0.000943	0.00165	CcSEcCtD
Levocabastine—Erythema—Doxorubicin—prostate cancer	0.000873	0.00152	CcSEcCtD
Levocabastine—Rash—Etoposide—prostate cancer	0.000866	0.00151	CcSEcCtD
Levocabastine—Dermatitis—Etoposide—prostate cancer	0.000865	0.00151	CcSEcCtD
Levocabastine—Headache—Etoposide—prostate cancer	0.00086	0.0015	CcSEcCtD
Levocabastine—Fatigue—Prednisone—prostate cancer	0.000849	0.00148	CcSEcCtD
Levocabastine—Cough—Epirubicin—prostate cancer	0.000823	0.00144	CcSEcCtD
Levocabastine—Asthenia—Docetaxel—prostate cancer	0.000819	0.00143	CcSEcCtD
Levocabastine—Nausea—Etoposide—prostate cancer	0.000816	0.00142	CcSEcCtD
Levocabastine—Asthenia—Capecitabine—prostate cancer	0.000793	0.00138	CcSEcCtD
Levocabastine—Dry mouth—Epirubicin—prostate cancer	0.000785	0.00137	CcSEcCtD
Levocabastine—Cough—Doxorubicin—prostate cancer	0.000762	0.00133	CcSEcCtD
Levocabastine—Dry mouth—Doxorubicin—prostate cancer	0.000727	0.00127	CcSEcCtD
Levocabastine—Rash—Docetaxel—prostate cancer	0.00072	0.00126	CcSEcCtD
Levocabastine—Dermatitis—Docetaxel—prostate cancer	0.000719	0.00125	CcSEcCtD
Levocabastine—Headache—Docetaxel—prostate cancer	0.000715	0.00125	CcSEcCtD
Levocabastine—Asthenia—Prednisone—prostate cancer	0.000706	0.00123	CcSEcCtD
Levocabastine—Rash—Capecitabine—prostate cancer	0.000697	0.00122	CcSEcCtD
Levocabastine—Dermatitis—Capecitabine—prostate cancer	0.000696	0.00121	CcSEcCtD
Levocabastine—Headache—Capecitabine—prostate cancer	0.000692	0.00121	CcSEcCtD
Levocabastine—Dyspnoea—Epirubicin—prostate cancer	0.000686	0.0012	CcSEcCtD
Levocabastine—Somnolence—Epirubicin—prostate cancer	0.000684	0.00119	CcSEcCtD
Levocabastine—Nausea—Docetaxel—prostate cancer	0.000678	0.00118	CcSEcCtD
Levocabastine—Fatigue—Epirubicin—prostate cancer	0.000664	0.00116	CcSEcCtD
Levocabastine—Pain—Epirubicin—prostate cancer	0.000658	0.00115	CcSEcCtD
Levocabastine—Nausea—Capecitabine—prostate cancer	0.000656	0.00115	CcSEcCtD
Levocabastine—Dyspnoea—Doxorubicin—prostate cancer	0.000635	0.00111	CcSEcCtD
Levocabastine—Somnolence—Doxorubicin—prostate cancer	0.000633	0.0011	CcSEcCtD
Levocabastine—Rash—Prednisone—prostate cancer	0.000621	0.00108	CcSEcCtD
Levocabastine—Dermatitis—Prednisone—prostate cancer	0.00062	0.00108	CcSEcCtD
Levocabastine—Headache—Prednisone—prostate cancer	0.000617	0.00108	CcSEcCtD
Levocabastine—Fatigue—Doxorubicin—prostate cancer	0.000614	0.00107	CcSEcCtD
Levocabastine—Pain—Doxorubicin—prostate cancer	0.000609	0.00106	CcSEcCtD
Levocabastine—Nausea—Prednisone—prostate cancer	0.000585	0.00102	CcSEcCtD
Levocabastine—Asthenia—Epirubicin—prostate cancer	0.000552	0.000964	CcSEcCtD
Levocabastine—Asthenia—Doxorubicin—prostate cancer	0.000511	0.000892	CcSEcCtD
Levocabastine—Rash—Epirubicin—prostate cancer	0.000485	0.000847	CcSEcCtD
Levocabastine—Dermatitis—Epirubicin—prostate cancer	0.000485	0.000846	CcSEcCtD
Levocabastine—Headache—Epirubicin—prostate cancer	0.000482	0.000841	CcSEcCtD
Levocabastine—Nausea—Epirubicin—prostate cancer	0.000457	0.000798	CcSEcCtD
Levocabastine—Rash—Doxorubicin—prostate cancer	0.000449	0.000783	CcSEcCtD
Levocabastine—Dermatitis—Doxorubicin—prostate cancer	0.000449	0.000783	CcSEcCtD
Levocabastine—Headache—Doxorubicin—prostate cancer	0.000446	0.000778	CcSEcCtD
Levocabastine—Nausea—Doxorubicin—prostate cancer	0.000423	0.000738	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—LPL—prostate cancer	0.000363	0.000849	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—GRP—prostate cancer	0.000362	0.000849	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—LPAR1—prostate cancer	0.000362	0.000849	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—IL2—prostate cancer	0.00036	0.000843	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PDGFRB—prostate cancer	0.000359	0.000842	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CB—prostate cancer	0.000356	0.000834	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PLXNB1—prostate cancer	0.000353	0.000827	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CX3CL1—prostate cancer	0.000352	0.000824	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—prostate cancer	0.000351	0.000822	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—RLN2—prostate cancer	0.00035	0.000821	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ITGB3—prostate cancer	0.00035	0.00082	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ANXA1—prostate cancer	0.00035	0.00082	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—PIK3CA—prostate cancer	0.000343	0.000804	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—CXCL8—prostate cancer	0.000342	0.000801	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GRPR—prostate cancer	0.00034	0.000796	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ERBB3—prostate cancer	0.00034	0.000796	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FGFR2—prostate cancer	0.000339	0.000795	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL2—prostate cancer	0.000327	0.000766	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TERT—prostate cancer	0.000326	0.000763	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—GNG5—prostate cancer	0.000326	0.000763	CbGpPWpGaD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—prostate cancer	0.000321	0.000751	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PLXNB1—prostate cancer	0.000321	0.000751	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—prostate cancer	0.00032	0.00075	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—HIF1A—prostate cancer	0.000311	0.000729	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GRPR—prostate cancer	0.000309	0.000723	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—LEP—prostate cancer	0.000304	0.000712	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CAV1—prostate cancer	0.000301	0.000706	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KDR—prostate cancer	0.000298	0.000698	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ESR1—prostate cancer	0.00029	0.00068	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PTHLH—prostate cancer	0.000284	0.000664	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—BAD—prostate cancer	0.000283	0.000664	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—AKT1—prostate cancer	0.00028	0.000657	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—MC2R—prostate cancer	0.000279	0.000654	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—prostate cancer	0.000275	0.000644	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APC—prostate cancer	0.000274	0.000643	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CG—prostate cancer	0.000274	0.000643	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—OR51E2—prostate cancer	0.000273	0.00064	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EGF—prostate cancer	0.000271	0.000635	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IRS1—prostate cancer	0.000271	0.000635	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—ANXA1—prostate cancer	0.000267	0.000625	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—WNT4—prostate cancer	0.000266	0.000622	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—GSK3B—prostate cancer	0.000263	0.000617	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—INS—prostate cancer	0.00026	0.000608	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CREBBP—prostate cancer	0.000254	0.000596	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—MC2R—prostate cancer	0.000253	0.000594	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IGF1—prostate cancer	0.000251	0.000588	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—EGFR—prostate cancer	0.00025	0.000585	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—BMPR1B—prostate cancer	0.00025	0.000585	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CALCA—prostate cancer	0.00025	0.000585	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PENK—prostate cancer	0.000249	0.000583	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL12—prostate cancer	0.000244	0.000571	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MAP2K1—prostate cancer	0.000243	0.000569	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CD—prostate cancer	0.000241	0.000565	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—PIK3CA—prostate cancer	0.000239	0.00056	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SERPINE1—prostate cancer	0.000238	0.000559	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—KRAS—prostate cancer	0.000236	0.000553	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—RGS17—prostate cancer	0.000232	0.000544	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FGF2—prostate cancer	0.000231	0.000541	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NOS3—prostate cancer	0.000228	0.000533	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PENK—prostate cancer	0.000226	0.000529	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—JAK2—prostate cancer	0.000221	0.000518	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—PIK3CA—prostate cancer	0.000217	0.000508	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MDM2—prostate cancer	0.000216	0.000506	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—MAP2K1—prostate cancer	0.000215	0.000505	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—ERBB2—prostate cancer	0.000213	0.000499	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—VIP—prostate cancer	0.000211	0.000495	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GNRH1—prostate cancer	0.000211	0.000495	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CB—prostate cancer	0.00021	0.000492	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—ADRB2—prostate cancer	0.000209	0.00049	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—RLN2—prostate cancer	0.000207	0.000485	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—LPAR1—prostate cancer	0.000205	0.00048	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GRP—prostate cancer	0.000205	0.00048	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PLCB2—prostate cancer	0.000203	0.000475	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CXCL8—prostate cancer	0.000202	0.000473	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HSD17B1—prostate cancer	0.000197	0.000463	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CTBP2—prostate cancer	0.000197	0.000463	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CDKN1B—prostate cancer	0.000197	0.000462	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—prostate cancer	0.000196	0.00046	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—AKT1—prostate cancer	0.000195	0.000457	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PDE4D—prostate cancer	0.000193	0.000453	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CASP3—prostate cancer	0.000193	0.000453	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL2—prostate cancer	0.000193	0.000452	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—IL6—prostate cancer	0.000192	0.00045	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—VIP—prostate cancer	0.000192	0.00045	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GNRH1—prostate cancer	0.000192	0.00045	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PLXNB1—prostate cancer	0.000189	0.000444	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CCND1—prostate cancer	0.000188	0.000441	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CTNNB1—prostate cancer	0.000186	0.000437	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—LPAR1—prostate cancer	0.000186	0.000436	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GRP—prostate cancer	0.000186	0.000436	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PLCB2—prostate cancer	0.000184	0.000431	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—GNG5—prostate cancer	0.000184	0.000431	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MMP9—prostate cancer	0.000183	0.000428	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GRPR—prostate cancer	0.000182	0.000427	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CDKN1A—prostate cancer	0.000182	0.000426	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PTEN—prostate cancer	0.000182	0.000426	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CX3CL1—prostate cancer	0.000181	0.000423	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—AKT1—prostate cancer	0.000177	0.000415	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL17RD—prostate cancer	0.000176	0.000412	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PDE4D—prostate cancer	0.000176	0.000412	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EP300—prostate cancer	0.000173	0.000406	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—SRC—prostate cancer	0.000168	0.000395	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—GNG5—prostate cancer	0.000167	0.000391	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—VEGFA—prostate cancer	0.000164	0.000384	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—STAT3—prostate cancer	0.000162	0.000381	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PTHLH—prostate cancer	0.00016	0.000375	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—WNT4—prostate cancer	0.000157	0.000368	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—JUP—prostate cancer	0.000157	0.000368	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MYC—prostate cancer	0.000151	0.000354	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—ANXA1—prostate cancer	0.000151	0.000353	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TGFB1—prostate cancer	0.000151	0.000353	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—RALBP1—prostate cancer	0.00015	0.000351	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MC2R—prostate cancer	0.00015	0.000351	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EGFR—prostate cancer	0.000148	0.000346	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTHLH—prostate cancer	0.000146	0.000341	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PRKACB—prostate cancer	0.000142	0.000334	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CALCA—prostate cancer	0.000141	0.000331	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—KRAS—prostate cancer	0.000139	0.000327	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PPP3CA—prostate cancer	0.000139	0.000325	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL12—prostate cancer	0.000138	0.000323	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—ANXA1—prostate cancer	0.000137	0.000321	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PENK—prostate cancer	0.000133	0.000313	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—prostate cancer	0.000133	0.000311	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—prostate cancer	0.000131	0.000307	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CALCA—prostate cancer	0.000128	0.0003	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—PIK3CA—prostate cancer	0.000128	0.0003	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GHR—prostate cancer	0.000127	0.000298	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—PIK3CA—prostate cancer	0.000127	0.000298	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PRKCQ—prostate cancer	0.000126	0.000295	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL12—prostate cancer	0.000125	0.000293	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TP53—prostate cancer	0.000124	0.00029	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—prostate cancer	0.000124	0.00029	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NRP1—prostate cancer	0.000122	0.000286	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—ADRB2—prostate cancer	0.000118	0.000277	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—VAV3—prostate cancer	0.000115	0.00027	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PRKCQ—prostate cancer	0.000114	0.000268	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—prostate cancer	0.000114	0.000266	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—IL6—prostate cancer	0.000113	0.000266	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VIP—prostate cancer	0.000113	0.000266	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GNRH1—prostate cancer	0.000113	0.000266	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—ITPR1—prostate cancer	0.000112	0.000262	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GRP—prostate cancer	0.00011	0.000257	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LPAR1—prostate cancer	0.00011	0.000257	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PLCB2—prostate cancer	0.000109	0.000255	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LRP2—prostate cancer	0.000109	0.000255	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—ADRB2—prostate cancer	0.000107	0.000252	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CX3CL1—prostate cancer	0.000107	0.00025	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—P4HB—prostate cancer	0.000107	0.00025	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—VAV3—prostate cancer	0.000105	0.000245	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HIST1H2BG—prostate cancer	0.000105	0.000245	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—AKT1—prostate cancer	0.000105	0.000245	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GRB7—prostate cancer	0.000104	0.000243	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PDE4D—prostate cancer	0.000104	0.000243	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—ITPR1—prostate cancer	0.000102	0.000238	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HIST1H4H—prostate cancer	0.000101	0.000237	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—CXCL8—prostate cancer	0.000101	0.000237	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—prostate cancer	0.000101	0.000236	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GNG5—prostate cancer	9.87e-05	0.000231	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTHLH—prostate cancer	8.6e-05	0.000201	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TGFBR1—prostate cancer	8.6e-05	0.000201	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AKR1C3—prostate cancer	8.46e-05	0.000198	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PRKACB—prostate cancer	8.41e-05	0.000197	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—THBS1—prostate cancer	8.2e-05	0.000192	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PPP3CA—prostate cancer	8.2e-05	0.000192	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ANXA1—prostate cancer	8.08e-05	0.000189	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PRKCZ—prostate cancer	7.93e-05	0.000186	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CG—prostate cancer	7.75e-05	0.000182	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PARP1—prostate cancer	7.66e-05	0.00018	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FGFR4—prostate cancer	7.66e-05	0.00018	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CALCA—prostate cancer	7.57e-05	0.000177	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL12—prostate cancer	7.39e-05	0.000173	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CG—prostate cancer	7.04e-05	0.000165	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CASP9—prostate cancer	6.96e-05	0.000163	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CD—prostate cancer	6.82e-05	0.00016	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PRKCQ—prostate cancer	6.75e-05	0.000158	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NGFR—prostate cancer	6.75e-05	0.000158	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MAP3K7—prostate cancer	6.67e-05	0.000156	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FGF10—prostate cancer	6.41e-05	0.00015	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ADRB2—prostate cancer	6.34e-05	0.000149	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—JAK2—prostate cancer	6.26e-05	0.000147	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—MAP2K1—prostate cancer	6.23e-05	0.000146	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CD—prostate cancer	6.19e-05	0.000145	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VAV3—prostate cancer	6.18e-05	0.000145	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TGFBR2—prostate cancer	6.1e-05	0.000143	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ITPR1—prostate cancer	6e-05	0.000141	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CB—prostate cancer	5.94e-05	0.000139	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IGF1R—prostate cancer	5.74e-05	0.000134	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—CXCL8—prostate cancer	5.71e-05	0.000134	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—JAK2—prostate cancer	5.68e-05	0.000133	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LPL—prostate cancer	5.5e-05	0.000129	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—IL2—prostate cancer	5.46e-05	0.000128	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PDGFRB—prostate cancer	5.45e-05	0.000128	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CB—prostate cancer	5.4e-05	0.000126	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ITGB3—prostate cancer	5.31e-05	0.000124	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—CXCL8—prostate cancer	5.19e-05	0.000122	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ERBB3—prostate cancer	5.15e-05	0.000121	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FGFR2—prostate cancer	5.14e-05	0.000121	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL2—prostate cancer	4.96e-05	0.000116	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TERT—prostate cancer	4.94e-05	0.000116	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HIF1A—prostate cancer	4.72e-05	0.000111	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LEP—prostate cancer	4.61e-05	0.000108	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CAV1—prostate cancer	4.57e-05	0.000107	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KDR—prostate cancer	4.52e-05	0.000106	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ESR1—prostate cancer	4.4e-05	0.000103	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—BAD—prostate cancer	4.3e-05	0.000101	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APC—prostate cancer	4.16e-05	9.75e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CG—prostate cancer	4.16e-05	9.75e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EGF—prostate cancer	4.11e-05	9.64e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IRS1—prostate cancer	4.11e-05	9.64e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—GSK3B—prostate cancer	3.99e-05	9.35e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—INS—prostate cancer	3.94e-05	9.23e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CREBBP—prostate cancer	3.86e-05	9.04e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IGF1—prostate cancer	3.81e-05	8.92e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—EGFR—prostate cancer	3.79e-05	8.88e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MAP2K1—prostate cancer	3.68e-05	8.63e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CD—prostate cancer	3.66e-05	8.57e-05	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PIK3CA—prostate cancer	3.62e-05	8.49e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SERPINE1—prostate cancer	3.62e-05	8.48e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—KRAS—prostate cancer	3.58e-05	8.39e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FGF2—prostate cancer	3.5e-05	8.2e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOS3—prostate cancer	3.45e-05	8.09e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—JAK2—prostate cancer	3.36e-05	7.86e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PIK3CA—prostate cancer	3.29e-05	7.71e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MDM2—prostate cancer	3.28e-05	7.68e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—ERBB2—prostate cancer	3.23e-05	7.57e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CB—prostate cancer	3.19e-05	7.47e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CXCL8—prostate cancer	3.06e-05	7.18e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CDKN1B—prostate cancer	2.99e-05	7.01e-05	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—AKT1—prostate cancer	2.96e-05	6.93e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CASP3—prostate cancer	2.93e-05	6.87e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL2—prostate cancer	2.93e-05	6.86e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—IL6—prostate cancer	2.91e-05	6.83e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CCND1—prostate cancer	2.85e-05	6.69e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CTNNB1—prostate cancer	2.83e-05	6.62e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MMP9—prostate cancer	2.77e-05	6.49e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CDKN1A—prostate cancer	2.76e-05	6.47e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTEN—prostate cancer	2.75e-05	6.45e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—AKT1—prostate cancer	2.69e-05	6.3e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EP300—prostate cancer	2.63e-05	6.16e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SRC—prostate cancer	2.55e-05	5.99e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VEGFA—prostate cancer	2.49e-05	5.83e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—STAT3—prostate cancer	2.46e-05	5.77e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MYC—prostate cancer	2.29e-05	5.36e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TGFB1—prostate cancer	2.28e-05	5.35e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EGFR—prostate cancer	2.24e-05	5.25e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—KRAS—prostate cancer	2.12e-05	4.96e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PIK3CA—prostate cancer	1.94e-05	4.55e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TP53—prostate cancer	1.88e-05	4.4e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—IL6—prostate cancer	1.72e-05	4.03e-05	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—AKT1—prostate cancer	1.59e-05	3.72e-05	CbGpPWpGaD
